Skip to content

Intrathecal Fentanyle Versus Dexamethasone in Gynacological Laparoscopic Surgeries

Intrathecal Fentanyle Versus Dexamethasone in Patients Under Going Gynacological Laparoscopic Surgeries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04779060
Enrollment
120
Registered
2021-03-03
Start date
2016-07-31
Completion date
2020-09-30
Last updated
2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperativ Pain

Brief summary

Laparoscopy was first introduced to the medical field of in the middle of the last century. It revolutionized the surgical interventions; it reduced the total medical expenditures and hastened postoperative recovery . General anaesthesia (GA) was considered the only anesthetic technique suitable for laparoscopic interventions, and several myths and facts prevented regional anaesthesia (RA) implementation. Respiratory and Cardiovascular impairment were the main aspects of concern which are thought to be best controlled by GA

Interventions

DRUGintrathecal fentanyle

25 mic fentanyle added to heavy bupivacaine for spinal anesthesia

DRUGdexamethasone

8 mg dexamethasone give intrathecally for spinal anaesthesia

DRUGsaline

normal saline will be mixed with bupivacaine intrathecally

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* ASA I, II * elective gynacological laparoscopic surgery

Exclusion criteria

* patient refusal * chronic kidney and hepatic diseases

Design outcomes

Primary

MeasureTime frameDescription
intraoperative pain60 minutespain measured by VAS score =from 0 to 10 0-3 is mild pain 3-6 moderate pain 6-10 sever pain

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026